Is Nortec Quimica SA halal to invest in?

As of September 2026, Nortec Quimica SA NRTQ3.SA is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Nortec Quimica SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Nortec Quimica SA using these criteria to determine its compliance status.

Can Muslims buy shares of Nortec Quimica SA?

Muslim investors may consider investing in Nortec Quimica SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Nortec Quimica SA classified as NOT COVERED?

Musaffa determines the Shariah status of Nortec Quimica SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Nortec Quimica SA updated?

The Shariah compliance status of Nortec Quimica SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Nortec Quimica SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Nortec Quimica SA?

You can check the latest Shariah compliance status of Nortec Quimica SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Nortec Quimica SA. Stock Analysis NRTQ3.SA

Brazil N/A Nano Cap

Nortec Química SA engages in the manufacture and supply of chemical and pharmacochemical products. The company is headquartered in Duque De Caxias, Rio De Janeiro. The company went IPO on 2013-05-28. The firm is primarily active in the production, marketing, import and export of chemical and pharmaceutical products. The company offers pharmaceutical ingredients serving the pharmaceutical industry in Latin America. The Company’s product portfolio includes hydrochloride isometheptene, diclofenac, lidocaine, didanosine, fosphenytoin and ephedrine sulfate, among others. The firm is also involved in the research and development of product technologies. Additionally, it provides technical assistance in the areas of trade, technology and manufacture of pharmaceutical related products. The firm operates in Brazil, South Africa, Germany, Argentina, Canada, Chile, Colombia, Korea, Costa Rica, Egypt, the United Arab Emirates, Ecuador, France, Guatemala, Netherlands, Indonesia, the United Kingdom, Iran, Israel, Italy, Jordan, Malaysia, Mexico, Palestine, Pakistan and Paraguay.

Nortec Quimica SA NRTQ3.SA